miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis.
about
Exploiting Epigenetic Alterations in Prostate Cancer.Identification of miR-30b-3p and miR-30d-5p as direct regulators of androgen receptor signaling in prostate cancer by complementary functional microRNA library screening.Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer Therapy.MicroRNAs in Bladder Outlet Obstruction: Relationship to Growth and Matrix Remodelling.miR-143 Induces the Apoptosis of Prostate Cancer LNCap Cells by Suppressing Bcl-2 Expression.MicroRNA-145 Inhibits Cell Migration and Invasion and Regulates Epithelial-Mesenchymal Transition (EMT) by Targeting Connective Tissue Growth Factor (CTGF) in Esophageal Squamous Cell Carcinoma.DNA Methylation and Urological Cancer, a Step Towards Personalized Medicine: Current and Future Prospects.Deciphering the function of non-coding RNAs in prostate cancer.Curcumin sensitizes prostate cancer cells to radiation partly via epigenetic activation of miR-143 and miR-143 mediated autophagy inhibition.Targeting MicroRNAs in Prostate Cancer Radiotherapy.Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer.Impact of novel miR-145-3p regulatory networks on survival in patients with castration-resistant prostate cancer.Nanoparticle-based targeted cancer strategies for non-invasive prostate cancer intervention.MiR-145 promotes TNF-α-induced apoptosis by facilitating the formation of RIP1-FADDcaspase-8 complex in triple-negative breast cancer.HDAC-Linked "Proliferative" miRNA Expression Pattern in Pancreatic Neuroendocrine TumorsIncreased MALAT1 expression contributes to cisplatin resistance in non-small cell lung cancer
P2860
Q33755160-490A45A8-6E3D-44FC-8164-E18325E4A98EQ36147506-F89BC634-D944-43AD-914C-259BE1DEFA77Q37629548-641D093C-2653-47B5-8E4F-8A43C7AEC8D7Q38650105-93B0E826-8D3D-4857-B16A-A17C7E764109Q38720187-989E56E9-A71D-4E26-9E2A-65FE2B018F8CQ38738233-B1F48DB3-2E7B-4AE9-B0FB-619BD83EE6D4Q38833395-A3BF2984-E73A-443C-9681-05F4B3D2BDAEQ38843392-FE30B894-5F0D-4C9C-857B-821B44E032B6Q38845840-A573ED8C-941F-4287-BA28-4C2457BCB26EQ41239908-7846C02E-8ED5-4B95-A4D5-8968A16F739AQ42517474-00BF838F-C66C-409F-9AF9-186CF6F7C3BDQ46133698-9002C245-8432-4F0E-953E-321B6867EF8DQ52718880-005448EA-35AC-409F-9178-F49DB8D6DF42Q53219892-ADD305E1-54DE-4EFB-852E-15E52CCAC513Q57823913-015EB5CC-B28F-4E0C-AA99-14A3C1AAD1C0Q58788865-628E24C6-63A0-4386-9DCE-4F91F99C542B
P2860
miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
miR-145 suppress the androgen ...... to prostate cancer prognosis.
@en
type
label
miR-145 suppress the androgen ...... to prostate cancer prognosis.
@en
prefLabel
miR-145 suppress the androgen ...... to prostate cancer prognosis.
@en
P2093
P2860
P356
P1433
P1476
miR-145 suppress the androgen ...... to prostate cancer prognosis.
@en
P2093
Anders Bjartell
Anders Edsjö
Hans Lilja
Olivia Larne
Yvonne Ceder
Zandra Hagman
P2860
P304
P356
10.1093/CARCIN/BGV063
P407
P577
2015-05-12T00:00:00Z